Leukemia, Myeloid, AcuteThe acute myeloid leukemias (AML) represent a heterogeneous group of malignancies derived from the pluripotent hematopoietic stem cell. These leukemias are generally characterized by genetic lesions that result in a combination of defects causing unregulated proliferation of cells ...
Acute myeloid leukemia (AML) is a type of blood cancer that starts in your bone marrow, which is the soft inner part of your bones where all your blood cells are made. AML usually begins in cells that turn into white blood cells but can also start in other blood-forming cells. When b...
Myeloid Leukemia May 31, published in the Cell magazine entitled "Genetic Inactivation ofCD33in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia," Dr. Saar Gill of the University of Pennsylvania School of Medicine and National Health The team led by Dr. Cynth...
said, "Our research highlighted an additional mode of action for the treatment known as eprenetapopt opening up its potential to work in a broader group of acute myeloid leukemia (AML) andmyelodysplastic syndrome(MDS) patients.
Steins M B,Bieker R,Padro T,et al.Thalidomide for the treatment of acute myeloid leukemia.Leukemia and Lymphoma. 2003Steins MB, Bieker R, Padro T, Kessler T, Kienast J, Berdel WE et al. Thalidomide for the treatment of acute myeloid leukemia. Leuk Lymphoma 2003; 44: 1489-1493....
Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow It occurs when the bone marrow, which is responsible for producing blood cells, starts making too many abnormal white blood cells called myeloblasts.
INTRODUCTION: Therapeutic strategies in patients with acute myeloid leukemia (AML) have not changed significantly over the last decades. Appropriate strategies are ultimately driven by the assessment of patients' fitness to define suitability for intensive induction chemotherapy, which produces high initial ...
Information arising from next generation sequencing of leukemia genome has shed important light on the heterogeneous and combinatorial driver events in acute myeloid leukemia (AML). It has also provided insight into its intricate signaling pathways operative in the disease pathogenesis. These have also ...
A novel assay that detects a unique molecular marker in patients with acute myeloid leukemia (AML) may revolutionize the way this disease is detected and treated according to a new report recently published inThe Journal of Molecular Diagnosticspublished by Elsevier. This assay may improve the detect...
In a study published on Monday, the team from the University of South Australia (UniSA) and SA Pathology's Center for Cancer Biology said they have found a way to suppress a protein that boosts resistance to drugs used to treat acute myeloid leukemia (AML) patients. ...